[1] |
Li Leilei, Shi Lei, Wang Lin, Li Hongwei, Xu Liran, Pang Yu, Song Yanzheng.
Clinical characteristics analysis of HIV-infected cases diagnosed with tuberculosis after surgery due to pulmonary nodules
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 266-273.
|
[2] |
Chen Wei, Li Xue, Liu Xiaoqiu, Li Yuhong, Ni Ni, Zhang Hui, Zhao Yanlin.
Interpretation and explanation about the National Tuberculosis Prevention and Control Plan (2024—2030)
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 130-136.
|
[3] |
Zhang Muli, Sun Zhaogang, Cao Tingming, Xie Zhongyao.
The value of three proteins in diagnosing Mycobacterium tuberculosis infection
[J]. Chinese Journal of Antituberculosis, 2024, 46(7): 808-814.
|
[4] |
Zhou Shuang, Zong Di, Li Shixue, Du Jian.
Analysis of influencing factors of tuberculosis patients’ medical experience with the internet hospital platform
[J]. Chinese Journal of Antituberculosis, 2024, 46(4): 424-432.
|
[5] |
Ma Shiran, Chen Suting, Huang Hairong, Duan Hongfei.
In vitro inhibitory and intracellular bactericidal activity of omadacycline against Mycobacterium abscessus
[J]. Chinese Journal of Antituberculosis, 2024, 46(12): 1442-1447.
|
[6] |
Wen Weinong, An Zhenxiang, He Yuanli, He Song, Liu Chuang, Sun Kai.
The causal relationship between immune cells and pulmonary tuberculosis: a mendelian randomization study
[J]. Chinese Journal of Antituberculosis, 2024, 46(12): 1519-1526.
|
[7] |
Ruan Yunzhou, Su Wei, Zhang Hui, Zhao Yanlin.
Historical evolution and prospect of rifampicin-resistant tuberculosis prevention and control in China
[J]. Chinese Journal of Antituberculosis, 2024, 46(10): 1166-1170.
|
[8] |
Zhou Wenyong, Wen Zexuan, Gao Mengxian, Li Tao, Zhang Hui, Wang Weibing.
Prediction of the effectiveness and impact of the free healthcare policy for tuberculosis in China
[J]. Chinese Journal of Antituberculosis, 2023, 45(9): 845-856.
|
[9] |
Ren Ruyan, Xue Yi, Liang Qian, Huang Hairong.
The mechanisms identification of the susceptibility discrepancy to isoniazid among clinical isolates of Mycobacterium kansasii
[J]. Chinese Journal of Antituberculosis, 2023, 45(8): 728-733.
|
[10] |
Zheng Rui, Zhao Mingrui, Yang Yuanzheng.
Meta-analysis of effectiveness and safety of the cycloserine-containing treatment for multidrug-resistant pulmonary tuberculosis in China
[J]. Chinese Journal of Antituberculosis, 2023, 45(7): 658-668.
|
[11] |
Song Yuanyuan, Xia Hui.
Survey on satisfaction of external quality assessment among tuberculosis laboratory network in China
[J]. Chinese Journal of Antituberculosis, 2023, 45(6): 559-565.
|
[12] |
Wang Yuanzhi, Long Meizhen, Liu Yiduo, Zhou Xiangmei.
Application value of Mycobacterium bovis lipopolysaccharide in the serological diagnosis of tuberculosis in animals
[J]. Chinese Journal of Antituberculosis, 2023, 45(4): 401-405.
|
[13] |
Xue Yong, Wu Xueqiong.
Interpretation of immune function status assessment in Expert consensus on immune function assessment and immunotherapy in patients with active tuberculosis (2021 edition)
[J]. Chinese Journal of Antituberculosis, 2023, 45(2): 134-138.
|
[14] |
Tian Lili, Chen Shuangshuang, Fan Ruifang, Zhang Jie, Wang Nenhan, Chen Hao, Dai Xiaowei, Ren Yixuan, Zhao Yanfeng, Li Chuanyou, Ding Beichuan, Li Bo, Yu Lan, Yi Junli, Wang Pei, Yang Xinyu, Song Weiping.
Clinical diagnostic value of combining four methods in detecting etiologically negative pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2023, 45(2): 144-150.
|
[15] |
Sun Yuxian, Liu Yuhong.
Interpretation of WHO operational handbook on tuberculosis: module 1: prevention-infection prevention and control
[J]. Chinese Journal of Antituberculosis, 2023, 45(12): 1120-1124.
|